Tags: Multiple myeloma,plasma cell cancer,bone marrow cancer,M protein,CRAB symptoms,monoclonal gammopathy,stem cell transplant,immunomodulatory drugs,proteasome inhibitors,skeletal survey,serum free light chain assay,bone lesions,hypercalcemia,renal insufficiency,anemiamultiple myelomaTransplantEligibility FactorsTexas
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | Crystal Phend MedPage Today Contributing editor at MedPage Today. Personal views. | ||
2 | Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA | Air Pollution Risky After Lung Transplant - 28 days ago | |
3 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
4 | Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA | Impact of Transplant Eligibility on Treatment Selection - about 1 month ago | |
5 | Shannon Firth MedPage Today Washington correspondent for MedPageToday. CUNYJschool pride. | ||
6 | Flora Graham Nature Writes Nature Briefing. Tweets own. On B’sky. London, United Kingdom | ||
7 | Joyce Frieden MedPage Today Washington editor at MedPage Today. Board member at AHCJ. Greater Washington, DC area | ||
8 | Isabella Cueto STAT News Journalist on chronic disease. | ||
9 | Katie Palmer STAT News Health tech reporter @statnews.
JSK Stanford alum. MA | ||
10 | Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania | The Next Frontier for mRNA Could Be Healing Damaged Organs - 3 months ago This Bag of Cells Could Grow New Livers Inside of People - 8 months ago |